Abstract | INTRODUCTION: AREAS COVERED: EXPERT OPINION: First choice in women below 35 years should be a combined low-risk pill, that is, with a second-generation progestin, with the lowest compliable dose of estrogen. Young women with risk factors of thrombosis such as age above 35 years, genetic predispositions, adiposity, polycystic ovary syndrome, diabetes, smoking, hypertension or migraine with aura should not use high-risk products, but should primarily consider progestin-only products, and be careful to use low-risk combined products.
|
Authors | Øjvind Lidegaard |
Journal | Expert opinion on drug safety
(Expert Opin Drug Saf)
Vol. 13
Issue 10
Pg. 1353-60
(Oct 2014)
ISSN: 1744-764X [Electronic] England |
PMID | 25227335
(Publication Type: Journal Article, Review)
|
Chemical References |
- Contraceptives, Oral, Combined
- Contraceptives, Oral, Hormonal
- Progestins
|
Topics |
- Adult
- Age Factors
- Contraceptives, Oral, Combined
(administration & dosage, adverse effects)
- Contraceptives, Oral, Hormonal
(administration & dosage, adverse effects)
- Female
- Genetic Predisposition to Disease
- Humans
- Myocardial Infarction
(chemically induced, epidemiology)
- Progestins
(administration & dosage, adverse effects)
- Risk Factors
- Stroke
(chemically induced, epidemiology)
- Thrombosis
(chemically induced, epidemiology, physiopathology)
|